Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality

  • Technology appraisal guidance
  • TA322
  • Published: 
  • Last updated: 

Tools and resources

Research recommendations

Guidance into practice